Support for Patients and Communities Reauthorization Act

This bill reauthorizes and extends funding for programs addressing substance use disorders and opioid addiction, including residential treatment for pregnant and postpartum women, first responder training, and community recovery initiatives. It increases funding levels for these programs, adds xylazine to Schedule III of controlled substances, and requires a study on remote monitoring for patients prescribed opioids. The bill also expands Medicaid coverage requirements for medication-assisted treatment and mandates reporting on mental health condition data alongside substance use disorder data, directly affecting individuals with substance use disorders, healthcare providers, and state and tribal governments.